<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="31867">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02020018</url>
  </required_header>
  <id_info>
    <org_study_id>13-001832</org_study_id>
    <nct_id>NCT02020018</nct_id>
  </id_info>
  <brief_title>Negative Pressure Wound Therapy for Prevention of Poststernotomy Infection</brief_title>
  <official_title>Negative Pressure Wound Therapy for Prevention of Wound Infection After Heart Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KCI USA, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Does a wound vac dressing prevent wound infection after heart surgery?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prospective study evaluates the role of negative pressure wound therapy or wound VAC as
      a dressing over the incision to prevent poststernotomy wound infection in high risk patients
      e.g. transplant, high dose steroid-dependent patients, severe COPD, type I insulin-dependent
      diabetics, and BMI&gt;30
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Wound infection after open heart surgery</measure>
    <time_frame>1-3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>reoperation for wound infection</measure>
    <time_frame>1-3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>length of stay</measure>
    <time_frame>1-3 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">950</enrollment>
  <condition>Surgical Wound Infection</condition>
  <arm_group>
    <arm_group_label>prospective group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This will be the high risk group that will have the wound VAC device (prevena) applied immediately postoperatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Retrospective arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard wound management group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>wound VAC (Prevena)</intervention_name>
    <description>negative pressure therapy that will be applied instead of the regular dressing immediately postoperatively in high risk patients and kept for 6-7 days</description>
    <arm_group_label>prospective group</arm_group_label>
    <other_name>negative pressure therapy</other_name>
    <other_name>wound VAC</other_name>
    <other_name>Prevena</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard wound dressing</intervention_name>
    <description>regular dressing that is applied immediately postoperatively for high risk patients in the operating room after strenotomy</description>
    <arm_group_label>Retrospective arm</arm_group_label>
    <other_name>poststernotomy wound dressing</other_name>
    <other_name>standard dressing after sternotomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. Transplant patients

          2. BMI &gt;30

          3. Type I (insulin-depenedent)diabtetics

          4. Severe COPD

          5. Steroid-dependent patients

          6. Previous Tracheostomy

        Exclusion criteria:

          1. BMI&lt;30

          2. Thoracotomy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hartzell Schaff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 18, 2013</lastchanged_date>
  <firstreceived_date>December 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Hartzell V. Schaff</investigator_full_name>
    <investigator_title>Professor of Surgery</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Surgical Wound Infection</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
